External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience MDA 2021
Roche and Genentech at

MDA 2021

March 15 - March 19
Virtual
mdaconference.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:45 PM
Duration 15mins Virtual
SUNFISH Part 2: 24-month efficacy and safety of risdiplam in patients with Type 2 or non-ambulant Type 3 spinal muscular atrophy (SMA)
Maryam Oskoui, John W Day, Nicolas Deconinick, Elena Mazzone, Andres Nascimento, Kayoko Saito, Carole Vuillerot, Giovanni Baranello, Odile Boespflug-Tanguy, Nathalie Goemans, Janbernd Kirschner, Anna Kostera-Pruszcyck, Laurent Servais, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Carmen Martin, Renata S Scalco, Hannah Staunton, Wai Yin Yeung, Eugenio Mercuri
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.